Preparation of Organometallic Ruthenium–Arene–Diaminotriazine Complexes as Binding Agents to DNA

The reactions of two diaminotriazine ligands 2,4‐diamino‐6‐(2‐pyridyl)‐1,3,5‐triazine (2‐pydaT) and 6‐phenyl‐2,4‐diamino‐1,3,5‐triazine (PhdaT) with ruthenium–arene precursors led to a new family of ruthenium(II) compounds that were spectroscopically characterized. Four of the complexes were cationic, with the general formula [(η⁶‐arene)Ru(κ²‐N,N‐2‐pydaT)Cl]X (X=BF₄, TsO; arene=p‐cymene: 1.BF4 , 1.TsO arene=benzene: 2.BF4 , 2.TsO ). The neutral cyclometalated complex [(η⁶‐p‐cymene)Ru(κ²‐C,N‐PhdaT*)Cl] ( 3 ) was also isolated. The structures of complexes 2.BF4 and 3.H2O were determined by X‐ray diffraction. Complex 1.BF4 underwent a partial reversible‐aquation process in water. UV/Vis and NMR spectroscopic measurements showed that the reaction was hindered by the addition of NaCl and was pH‐controlled in acidic solution. At pH 7.0 (sodium cacodylate) Ru–Cl complex 1.BF4 was the only species present in solution, even at low ionic strength. However, in alkaline medium (KOH), complex 1.BF4 underwent basic hydrolysis to afford a Ru–OH complex ( 5 ). Fluorimetric studies revealed that the interaction of complex 1.BF4 with DNA was not straightforward; instead, its main features were closely linked to ionic strength and to the [DNA]/complex ratio. The bifunctional complex 1.BF4 was capable of interacting concurrently through both its p‐cymene and 2‐pydaT groups. Cytotoxicity and genotoxicity studies showed that, contrary to the expected behavior, the complex species was biologically inactive; the formation of a Ru–OH complex could be responsible for such behavior.     

Identification of the Structural Determinants for Anticancer Activity of a Ruthenium Arene Peptide Conjugate

Organometallic Ru(arene)–peptide bioconjugates with potent in vitro anticancer activity are rare. We have prepared a conjugate of a Ru(arene) complex with the neuropeptide [Leu⁵]‐enkephalin. [Chlorido(η⁶‐p‐cymene)(5‐oxo‐κO‐2‐{(4‐[(N‐tyrosinyl‐glycinyl‐glycinyl‐phenylalanyl‐leucinyl‐NH₂)propanamido]‐1H‐1,2,3‐triazol‐1‐yl)methyl}‐4H‐pyronato‐κO)ruthenium(II)] ( 8 ) shows antiproliferative activity in human ovarian carcinoma cells with an IC₅₀ value as low as 13 μM , whereas the peptide or the Ru moiety alone are hardly cytotoxic. The conjugation strategy for linking the Ru(cym) (cym=η⁶‐p‐cymene) moiety to the peptide involved N‐terminal modification of an alkyne‐[Leu⁵]‐enkephalin with a 2‐(azidomethyl)‐5‐hydroxy‐4H‐pyran‐4‐one linker, using Cu^I‐catalyzed alkyne–azide cycloaddition (CuAAC), and subsequent metallation with the Ru(cym) moiety. The ruthenium‐bioconjugate was characterized by high resolution top‐down electrospray ionization mass spectrometry (ESI‐MS) with regard to peptide sequence, linker modification and metallation site. Notably, complete sequence coverage was obtained and the Ru(cym) moiety was confirmed to be coordinated to the pyronato linker. The ruthenium‐bioconjugate was analyzed with respect to cytotoxicity‐determining constituents, and through the bioconjugate models [{2‐(azidomethyl)‐5‐oxo‐κO‐4H‐pyronato‐κO}chloride (η⁶‐p‐cymene)ruthenium(II)] ( 5 ) and [chlorido(η⁶‐p‐cymene){5‐oxo‐κO‐2‐([(4‐(phenoxymethyl)‐1H‐1,2,3‐triazol‐1‐yl]methyl)‐4H‐pyronato‐κO}ruthenium(II)] ( 6 ) the Ru(cym) fragment with a triazole‐carrying pyronato ligand was identified as the minimal unit required to achieve in vitro anticancer activity.     

Highly Efficient Redox Isomerisation of Allylic Alcohols Catalysed by Pyrazole‐Based Ruthenium(IV) Complexes in Water: Mechanisms of Bifunctional Catalysis in Water

The catalytic activity of ruthenium(IV) ([Ru(η³:η³‐C₁₀H₁₆)Cl₂L]; C₁₀H₁₆=2,7‐dimethylocta‐2,6‐diene‐1,8‐diyl, L=pyrazole, 3‐methylpyrazole, 3,5‐dimethylpyrazole, 3‐methyl‐5‐phenylpyrazole, 2‐(1H‐pyrazol‐3‐yl)phenol or indazole) and ruthenium(II) complexes ([Ru(η⁶‐arene)Cl₂(3,5‐dimethylpyrazole)]; arene=C₆H₆, p‐cymene or C₆Me₆) in the redox isomerisation of allylic alcohols into carbonyl compounds in water is reported. The former show much higher catalytic activity than ruthenium(II) complexes. In particular, a variety of allylic alcohols have been quantitatively isomerised by using [Ru(η³:η³‐C₁₀H₁₆)Cl₂(pyrazole)] as a catalyst; the reactions proceeded faster in water than in THF, and in the absence of base. The isomerisations of monosubstituted alcohols take place rapidly (10–60 min, turn‐over frequency=750–3000 h^?1) and, in some cases, at 35 °C in 60 min. The nature of the aqueous species formed in water by this complex has been analysed by ESI‐MS. To analyse how an aqueous medium can influence the mechanism of the bifunctional catalytic process, DFT calculations (B3LYP) including one or two explicit water molecules and using the polarisable continuum model have been carried out and provide a valuable insight into the role of water on the activity of the bifunctional catalyst. Several mechanisms have been considered and imply the formation of aqua complexes and their deprotonated species generated from [Ru(η³:η³‐C₁₀H₁₆)Cl₂(pyrazole)]. Different competitive pathways based on outer‐sphere mechanisms, which imply hydrogen‐transfer processes, have been analysed. The overall isomerisation implies two hydrogen‐transfer steps from the substrate to the catalyst and subsequent transfer back to the substrate. In addition to the conventional Noyori outer‐sphere mechanism, which involves the pyrazolide ligand, a new mechanism with a hydroxopyrazole complex as the active species can be at work in water. The possibility of formation of an enol, which isomerises easily to the keto form in water, also contributes to the efficiency in water.     

Transfer hydrogenation of ketones catalysed by half‐sandwich (η6‐p‐cymene) ruthenium(II) complexes incorporating benzoylhydrazone ligands

Neutral half‐sandwich η⁶‐p ‐cymene ruthenium(II) complexes of general formula [Ru(η⁶‐p ‐cymene)Cl(L)] (HL = monobasic O, N bidendate benzoylhydrazone ligand) have been synthesized from the reaction of [Ru(η⁶‐p ‐cymene)(μ‐Cl)Cl]₂ with acetophenone benzoylhydrazone ligands. All the complexes have been characterized using analytical and spectroscopic (Fourier transform infrared, UV–visible, ¹H NMR, ¹³C NMR) techniques. The molecular structures of three of the complexes have been determined using single‐crystal X‐ray diffraction, indicating a pseudo‐octahedral geometry around the ruthenium(II) ion. All the ruthenium(II) arene complexes were explored as catalysts for transfer hydrogenation of a wide range of aromatic, cyclic and aliphatic ketones with 2‐propanol using 0.1 mol% catalyst loading, and conversions of up to 100% were obtained. Further, the influence of other variables on the transfer hydrogenation reaction, such as base, temperature, catalyst loading and substrate scope, was also investigated.     

Ruthenium–Arene–β‐Carboline Complexes as Potent Inhibitors of Cyclin‐Dependent Kinase 1: Synthesis,Characterization and Anticancer Mechanism Studies

A series of Ru^II–arene complexes ( 1 – 6 ) of the general formula [(η⁶‐arene)Ru(L)Cl]PF₆ (arene=benzene or p‐cymene; L=bidentate β‐carboline derivative, an indole alkaloid with potential cyclin‐dependent kinases (CDKs) inhibitory activities) is reported. All the complexes were fully characterized by classical analytical methods, and three were characterized by X‐ray crystallography. Hydrolytic studies show that β‐carboline ligands play a vital role in their aqueous behaviour. These complexes are highly active in vitro, with the most active complex 6 displaying a 3‐ to 12‐fold higher anticancer activity than cisplatin against several cancer cell lines. Interestingly, the complexes are able to overcome cross‐resistance to cisplatin, and show much lower cytotoxicity against normal cells. Complexes 1 – 6 may directly target CDK1, because they can block cells in the G2M phase, down‐regulate the expression of CDK1 and cyclin B1, and inhibit CDK1/cyclin B in vitro. Further mechanism studies show that the complexes can effectively induce apoptosis through mitochondrial‐related pathways and intracellular reactive oxygen species (ROS) elevation.     

Maltol‐Derived Ruthenium–Cymene Complexes with Tumor Inhibiting Properties: The Impact of Ligand–Metal Bond Stability on Anticancer Activity In Vitro

Organometallic ruthenium–arene compounds bearing a maltol ligand have been shown to be nearly inactive in in vitro anticancer assays, presumably due to the formation of dimeric Ru^II species in aqueous solutions. In an attempt to stabilize such complexes, [Ru(η⁶‐p‐cymene)(XY)Cl] (XY=pyrones or thiopyrones) complexes with different substitution pattern of the (thio)pyrone ligands have been synthesized, their structures characterized spectroscopically, and their aquation behavior investigated as well as their tumor‐inhibiting potency. The aquation behavior of pyrone systems with electron‐donating substituents and of thiopyrone complexes was found to be significantly different from that of the maltol‐type complex reported previously. However, the formation of the dimer can be excluded as the primary reason for the inactivity of the complex because some of the stable compounds are not active in cancer cell lines either. In contrast, studies of their reactivity towards amino acids demonstrate different reactivities of the pyrone and thiopyrone complexes, and the higher stability of the latter probably renders them active against human tumor cells.     

Hydrogenation of nitroaromatics to anilines catalyzed by air‐stable arene ruthenium (II)–NNN pincer complexes

A series of air‐stable, phosphine‐free arene ruthenium (II)–NNN pincer complexes (RuL, RuL¹, RuL² and RuL³) have been synthesized and characterized by spectroscopic and single‐crystal X‐ray analysis. Further, arene ruthenium (II)–NNN pincer complexes have been used as catalyst for hydrogenation of nitroaromatics into aniline in the presence of NaBH₄ at room temperature. The catalytic process suggested highly chemo‐selective nitroreduction with wide functional group tolerance.     

Selenoquinones Stabilized by Ruthenium(II) Arene Complexes: Synthesis,Structure, and Cytotoxicity

A new series of monoselenoquinone and diselenoquinone π complexes, [(η⁶‐p‐cymene)Ru(η⁴‐C₆R₄SeE)] (R=H, E=Se ( 6 ); R=CH₃, E=Se ( 7 ); R=H, E=O ( 8 )), as well as selenolate π complexes [(η⁶‐p‐cymene)Ru(η⁵‐C₆H₃R₂Se)][SbF₆] (R=H ( 9 ); R=CH₃ ( 10 )), stabilized by arene ruthenium moieties were prepared in good yields through nucleophilic substitution reactions from dichlorinated‐arene and hydroxymonochlorinated‐arene ruthenium complexes [(η⁶‐p‐cymene)Ru(C₆R₄XCl)][SbF₆]₂ (R=H, X=Cl ( 1 ); R=CH₃, X=Cl ( 2 ); R=H, X=OH ( 3 )) as well as the monochlorinated π complexes [(η⁶‐p‐cymene)Ru(η⁵‐C₆H₃R₂Cl)][SbF₆]₂ (R=H ( 4 ); R=CH₃ ( 5 )). The X‐ray crystallographic structures of two of the compounds, [(η⁶‐p‐cymene)Ru(η⁴‐C₆Me₄Se₂)] ( 7 ) and [(η⁶‐p‐cymene)Ru(η⁴‐C₆H₄SeO)] ( 8 ), were determined. The structures confirm the identity of the target compounds and ascertain the coordination mode of these unprecedented ruthenium π complexes of selenoquinones. Furthermore, these new compounds display relevant cytotoxic properties towards human ovarian cancer cells.     

Synthesis and Structures of Arene Ruthenium (II)–NHC Complexes: Efficient Catalytic α‐alkylation of ketones via Hydrogen Auto Transfer Reaction

A panel of six new arene Ru (II)‐NHC complexes 2a‐f , (NHC = 1,3‐diethyl‐(5,6‐dimethyl)benzimidazolin‐2‐ylidene 1a , 1,3‐dicyclohexylmethyl‐(5,6‐dimethyl)benzimidazolin‐2‐ylidene 1b and 1,3‐dibenzyl‐(5,6‐dimethyl)benzimidazolin‐2‐ylidene 1c ) were synthesized from the transmetallation reaction of Ag‐NHC with [(η⁶‐arene)RuCl₂]₂ and characterized. The ruthenium (II)‐NHC complexes 2a‐f were developed as effective catalysts for α‐alkylation of ketones and synthesis of bioactive quinoline using primary/amino alcohols as coupling partners respectively. The reactions were performed with 0.5 mol% catalyst load in 8 h under aerobic condition and the maximum yield was up to 96%. Besides, the different alkyl wingtips on NHC and arene moieties were studied to differentiate the catalytic robustness of the complexes in the transformations.     

Novel microwave synthesis of half‐sandwich [(η6‐C6H6)Ru] complexes and an evaluation of the biological activity and biochemical reactivity

We have used a novel microwave‐assisted method to synthesize a pair of half‐sandwich ruthenium–arene–thiosemicarbazone complexes of the type [(η⁶‐C₆H₆Ru(TSC)Cl]PF₆. The thiosemicarbazone (TSC) ligands are 2‐(anthracen‐9‐ylmethylene)hydrazinecarbothioamide and 2‐(anthracen‐9‐ylmethylene)‐N‐ethylhydrazinecarbothioamide derived from 9‐anthraldehyde. The complexes are moderately strong binders of DNA, with binding constants of 10⁴ m ^?1. They are also strong binders of human serum albumin, having binding constants of the order of 10⁵ m ^?1. The complexes show some in vitro anticancer activity against human colon cancer cells, Caco‐2 and HCT‐116, with positive therapeutic indices. They did not show any activity as antibacterial agents against the organisms that were studied. Copyright © 2013 John Wiley & Sons, Ltd.     

Cavity‐Shaped Ligands: Calix[4]arene‐Based Monophosphanes for Fast Suzuki–Miyaura Cross‐Coupling

Five conical calix[4]arenes that have a PPh₂ group as the sole functional group anchored at their upper rim were assessed in palladium‐catalysed cross‐coupling reactions of phenylboronic acid with aryl halides (dioxane, 100 °C, NaH). With arylbromides, remarkably high activities were obtained with the catalytic systems remaining stable for several days. The performance of the ligands is comparable to a Buchwald‐type triarylphosphane, namely, (2′‐methyl[1,1′‐biphenyl]‐2‐yl)diphenylphosphane, which in contrast to the calixarenyl phosphanes tested may display chelating behaviour in solution. With the fastest ligand, 5‐diphenylphosphanyl‐25,26,27,28‐tetra(p‐methoxy)benzyloxy‐calix[4]arene ( 8 ), the reaction turnover frequency for the arylation of 4‐bromotoluene was 321 000 versus 214 000 mol(ArBr).mol(Pd)^?1. h^?1 for the reference ligand. The calixarene ligands were also efficient in Suzuki cross‐coupling reactions with aryl chlorides. Thus, by using 1 mol % of [Pd(OAc)₂] associated with one of the phosphanes, full conversion of the deactivated arenes 4‐chloroanisole and 4‐chlorotoluene was observed after 16 h. The high performance of the calixarenyl–phosphanes in Suzuki–Miyaura coupling of aryl bromides possibly relies on their ability to stabilise a monoligand [Pd⁰L(ArBr)] species through supramolecular binding of the Pd‐bound arene inside the calixarene cavity.     

Modifying the structure of dinuclear ruthenium complexes with antitumor activity

In order to modulate the structure of a recently developed series of antitumor‐active, dinuclear Ru(II)–arene compounds, complexes 1c – 4c were synthesized. The complexes were modified with respect to their pyridinone moieties and the spacer linking the two metal centers. More particularly, the series of dinuclear ruthenium(II) complexes was extended to compounds with longer spacers, i.e. tetradecane and 3,7,10‐trioxotridecane, and the pyridinone ring was modified by replacing the methyl group by an ethyl group and by shifting the position of the methyl group. The organometallic ruthenium compounds were obtained from the reaction between [RuCl₂(η⁶‐p‐isopropyltoluene)]₂ and ligands 1b – 4b with yields ranging from 41 to 67%. All compounds were characterized by standard methods: MS, ¹H and ¹³C NMR spectroscopy and elemental analysis. Copyright © 2008 John Wiley & Sons, Ltd.     

Hoop‐Shaped Condensed Aromatic Systems: Synthesis and Structure of Iron– and Ruthenium–Hepta(organo)[60]fullerene Complexes

Potassium reduction of iron– and ruthenium–penta(organo)[60]fullerene complexes, [M(η⁵‐C₆₀R₅)(η⁵‐Cp)] ( 1 a : M=Fe, R=Ph; 1 b : M=Fe, R=Me; 1 c : M=Ru, R=Ph; 1 d : M=Ru, R=Me; Cp=C₅H₅) gave mono‐ and dianions of these complexes. Treatment of the dianion 1 a with α‐bromodiphenylmethane gave three different iron–hepta(organo)[60]fullerenes, [Fe{η⁵‐C₆₀Ph₅(CHPh₂)₂}(η⁵‐Cp)], as a mixture of regioisomers. All three compounds were fully characterized by physical methods, including X‐ray crystallography and electrochemical measurements. One of the three compounds contains a new hoop‐shaped condensed aromatic system.     

Synthesis of Imines via Reactions of Benzyl Alcohol with Amines Using Half‐Sandwich (η6‐p‐cymene) Ruthenium(II) Complexes Stabilised by 2‐aminofluorene Derivatives

A new class of half‐sandwich (η⁶‐p‐cymene) ruthenium(II) complexes supported by 2‐aminofluorene derivatives [Ru(η⁶‐p‐cymene)(Cl)(L)] ( L  = 2‐(((9H‐fluoren‐2‐yl)imino)methyl)phenol ( L ¹ ), 2‐(((9H‐fluoren‐2‐yl)imino)methyl)‐3‐methoxyphenol ( L ² ), 1‐(((9H‐fluoren‐2‐yl)imino)methyl)naphthalene‐2‐ol ( L ³ ) and N‐((1H‐pyrrol‐2‐yl)methylene)‐9H‐fluorene‐2‐amine ( L ⁴ )) were synthesized. All compounds were fully characterized by analytical and spectroscopic techniques (IR, UV–Vis, NMR) and also by mass spectrometry. The solid state molecular structures of the complexes [Ru(η⁶‐p‐cymene)(Cl)(L²)], [Ru(η⁶‐p‐cymene)(Cl)(L³)] and [Ru(η⁶‐p‐cymene)(Cl)(L⁴)] revealed that the 2‐aminofluorene and p‐cymene moieties coordinate to ruthenium(II) in a three‐legged piano‐stool geometry. The synthesized complexes were used as catalysts for the dehydrogenative coupling of benzyl alcohol with a range of amines (aliphatic, aromatic and heterocyclic). The reactions were carried out under thermal heating, ultrasound and microwave assistance, using solvent or solvent free conditions, and the catalytic performance was optimized regarding the solvent, the type of base, the catalyst loading and the temperature. Moderately high to very high isolated yields were obtained using [Ru(η⁶‐p‐cymene)(Cl)(L⁴)] at 1 mol%. In general, microwave irradiation produced better yields than the other two techniques irrespective of the nature of the substituents.     

Synthesis,cytotoxicity and anti‐metastatic properties of new pyridyl–thiazole arene ruthenium(II) complexes

A series of novel ruthenium(II)–cymene complexes ( 1 – 8 ) containing substituted pyridyl–thiazole ligands, [Ru(η⁶‐p‐cymene)(L)Cl]Cl (L = N,N‐chelating derivatives), have been synthesized and characterized using elemental analysis, infrared, ¹H NMR and ¹³C NMR spectroscopies and mass spectrometry. All these complexes not only display marked cytotoxicity in vitro against three different human cancer cell lines (HeLa, A549 and MDA‐MB‐231), but also exhibit promising anti‐metastatic activity at sub‐cytotoxic concentrations. Cell cycle analysis shows that the ruthenium(II) complex‐induced growth inhibition was mainly caused by S‐phase cell cycle arrest. Further protein level analysis suggests that compound 5 may exert antitumor activity via a p53‐independent mechanism.     

(η6‐Hexamethylbenzene)(mesidine)­ditriflatoruthenium(II)

The crystal structure of the title complex, (η⁶‐hexamethylbenzene)bis(trifluoromethanesulfonato‐O)(2,4,6‐trimethylanil­ine‐N)ruthenium(II), [Ru(CF₃O₃S)₂(C₁₂H₁₈)(C₉H₁₃N)], is described. The complex has the classic three‐legged piano‐stool structure with a planar arene 1.667 Å from the metal, two monodentate O‐bound tri­fluoro­methane­sulfonate ligands [Ru—O 2.169 (2) and 2.174 (2) Å] and one N‐bound mesidine ligand [Ru—N 2.198 (2) Å]. The Ru—N distance is relatively long and the average Ru—O distance is relatively short when compared with previously characterized Ru^II complexes.     

Improved molecular weight control in ring‐opening metathesis polymerization reactions in organic and aqueous media using N‐heterocyclic carbene–ruthenium arene/alkyne catalyst systems

A binary catalytic system, RuCl₂(N‐heterocyclic carbene)(p‐cymene)/alkyne, was developed for improved molecular weight control in ring‐opening metathesis polymerization (ROMP) reactions of norbornene derivatives in organic and aqueous media. Monometallic ruthenium arene compounds were activated using aryl and aliphatic terminal alkynes to form highly active metathesis species. The effects of alkyne structure and concentration on the overall catalytic activity were systematically investigated. The catalytic activity of the metathesis active species can be tuned by varying alkyne substituents. Also, the initiation rate of the ROMP reaction can be tuned by increasing the alkyne‐to‐Ru ratio. ROMP polymers with a wide range of molecular weights (91–832 kDa) were isolated in organic media, whereas polymers with a molecular weight range of 110–280 kDa with average particle sizes of 150–250 nm were isolated in aqueous media. Copyright © 2016 John Wiley & Sons, Ltd.     

Enhanced Anion Binding from Unusual Coordination Modes of Bis(thiourea) Ligands in Platinum Group Metal Complexes

Treatment of a range of bis(thiourea) ligands with inert organometallic transition‐metal ions gives a number of novel complexes that exhibit unusual ligand binding modes and significantly enhanced anion binding ability. The ruthenium(II) complex [Ru(η⁶‐p‐cymene)(κS,S′,N‐ L³ ?H)]⁺ ( 2 b ) possesses juxtaposed four‐ and seven‐membered chelate rings and binds anions as both 1:1 and 2:1 host guest complexes. The pyridyl bis(thiourea) complex [Ru(η⁶‐p‐cymeme)(κS,S′,N_py‐ L⁴ )]²⁺ ( 4 ) binds anions in both 1:1 and 1:2 species, whereas the free ligand is ineffective because of intramolecular NH???N hydrogen bonding. Novel palladium(II) complexes with nine‐ and ten‐membered chelate rings are also reported.     

Synthesis and characterization of new complexes of the type [Ru(CO)2Cl2 (2‐phenyl‐1,8‐naphthyridine‐kN) (2‐phenyl‐1,8‐naphthyridine‐kN′)]. Preliminary applications in homogeneous catalysis

Novel ruthenium (II) complexes were prepared containing 2‐phenyl‐1,8‐naphthyridine derivatives. The coordination modes of these ligands were modified by addition of coordinating solvents such as water into the ethanolic reaction media. Under these conditions 1,8‐naphthyridine (napy) moieties act as monodentade ligands forming unusual [Ru(CO)₂Cl₂(η¹‐2‐phenyl‐1,8‐naphthyridine‐ kN )(η¹‐2‐phenyl‐1,8‐naphthyridine‐kN′)] complexes. The reaction was reproducible when different 2‐phenyl‐1,8‐naphthyridine derivatives were used. On the other hand, when dry ethanol was used as the solvent we obtained complexes with napy moieties acting as a chelating ligand. The structures proposed for these complexes were supported by NMR spectra, and the presence of two ligands in the [Ru(CO)₂Cl₂(η¹‐2‐phenyl‐1,8‐naphthyridine‐ kN )(η¹‐2‐phenyl‐1,8‐naphthyridine‐kN′)] type complexes was confirmed using elemental analysis. All complexes were tested as catalysts in the hydroformylation of styrene showing moderate activity in N,N′‐dimethylformamide. Copyright © 2008 John Wiley & Sons, Ltd.     

Synthesis of a Configurationally Stable Three‐Legged Piano‐Stool Complex

A transition metal Lewis acid with metal‐centered chirality is obtained by η⁶:η¹:η¹ coordination of a 1,3‐disubstituted arene with a phosphane and a pyrazole tether (PArN) to ruthenium. The three‐legged piano‐stool complex [{η⁶:η¹:η¹‐(PArN)}Ru(H₂O)]²⁺ (structure depicted) displays remarkable configurational stability. Its planar chiral, neutral precursor [{η⁶:η¹‐(PArN)}RuCl₂] can be resolved by preparative HPLC.